Clinical Study Details

Sponsored multicenter depot lupron study

This multicenter company-sponsored study randomizes children with central precocious puberty (starting in girls before 8 and boys before 9) to two different doses (11.25 mg and 30 mg) of 3 month depot lupron.  The study has visits in the General Clinical Research Center every month for the first three months and then every 3 months.  All study requirements and medication are provided by the sponsor.  Enrollment is expected to close by early autumn 2009.  

To be eligible for this study you must:

If your child has any of the following, he or she cannot take part in the study:

Contacts:  Dr Kirk Neely and Eileen Durham RN"